DETAILS OF TECHNOLOGY
The dermatoscope generates a beam of light that falls on the cutaneous surface at an angle of 20°, allowing visualisation of the dermoscopic characteristics resulting from the presence of melanin and haemoglobin in the different skin layers. The usual magnification provided by the dermatoscope is ten-fold.
PATIENT GROUP AND USE
The use of dermoscopy enables:
• monitoring of pigmented lesions,
• diagnosis of melanoma,
• the physician to understand naevus morphology beyond what is possible by naked-eye examination alone, and
• recognition of different populations of naevi characterised by similar morphological patterns and pigment distribution. As with many cancer diagnoses, if melanoma is diagnosed early the survival rates are good; most stage 1 and stage 2 melanomas can be cured. A recent study on the recognition of skin malignancies showed that GPs in the UK missed onethird of malignancies, 2 and one systematic review showed the sensitivity for detection of malignant melanoma was as low as 81% in dermatologists and only 41% in primary care physicians.
IMPORTANCE

3
PREVIOUS RESEARCH
The performance of dermoscopy has been widely investigated, and two meta-analyses have confirmed its use increases diagnostic accuracy by between 5% and 30% compared with clinical visual inspection. [4] [5] [6] In one multicentre European trial, GPs were given a 1-day training course in skin cancer detection and dermoscopic evaluation, and randomly assigned to the dermoscopy evaluation arm or naked-eye evaluation arm. 7 During a 16-month period, 73 physicians evaluated 2522 patients with skin lesions. All patients were re-evaluated by expert dermatologists. Sensitivity was significantly higher using dermoscopy (79% versus 54%, P<0.01), with identical specificity (71%). Histopathological examination of equivocal lesions revealed 23 malignant skin tumours missed by GPs performing naked-eye observation and only six missed by GPs using dermoscopy (P<0.01). The study concluded that the use of dermoscopy improves the ability of GPs to triage lesions that are suggestive of skin cancer.
In addition, tools such as a three-point checklist to identify melanoma (asymmetry, atypical network, and blue-white structures) and the CASH score (colours, architectural disorder, symmetry, homogeneity/heterogeneity), which can be used in conjunction with dermoscopy, have been developed; and validation studies have shown overall good interobserver reproducibility. [8] [9] [10] An alternative to dermoscopy called MoleMate™, which uses spectrophotometric intracutaneous analysis (SIAscopy) along with an algorithm specifically developed for primary care, has been evaluated in a multicentre randomised controlled trial in the UK. 11 The trial was completed in December 2010; however, the findings are as yet unpublished. Results of this study will be relevant to the diagnosis of melanoma in primary care.
COST-EFFECTIVENESS AND ECONOMIC IMPACT
There is no published evidence on the cost and cost-effectiveness of the use of dermoscopy for the diagnosis of melanoma in primary care. Several researchers have commented that dermoscopy in routine practice may have major implications in large-scale melanoma screening, with a reduction in the dermatological surgery workload of false-positive lesions, leading to cost savings, reduced morbidity, and less scarring. 12 It may be cost-effective due to the decreased number of excised benign lesions and the early detection of melanomas. 13 In terms of patient-reported outcomes, a study estimating patients' willingness to pay for handheld dermoscopy, digital dermoscopy, and teledermoscopy was reported to be 40% below a hypothetical method promising 100% accuracy, yet higher than that reported for naked-eye inspection. 14 Future research is needed to assess whether the use of dermatoscopes in a primary care setting is cost-effective in terms of early detection of melanomas. 
Relevant guidelines
